VZOLE voriconazole 200 mg film-coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

vzole voriconazole 200 mg film-coated tablets blister pack

arrotex pharmaceuticals pty ltd - voriconazole, quantity: 200 mg - tablet, film coated - excipient ingredients: lactose monohydrate; pregelatinised maize starch; maize starch; croscarmellose sodium; povidone; silicon dioxide; magnesium stearate; titanium dioxide; hypromellose; triacetin - voriconazole is indicated for treatment of the following fungal infections:invasive aspergillosis. serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). serious fungal infections caused by scedosporium spp and fusarium spp. other serious fungal infections, in patients intolerant of, or refractory to, other therapy. prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

VZOLE voriconazole 50 mg film-coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

vzole voriconazole 50 mg film-coated tablets blister pack

arrotex pharmaceuticals pty ltd - voriconazole, quantity: 50 mg - tablet, film coated - excipient ingredients: lactose monohydrate; pregelatinised maize starch; maize starch; croscarmellose sodium; povidone; silicon dioxide; magnesium stearate; titanium dioxide; hypromellose; triacetin - voriconazole is indicated for treatment of the following fungal infections:invasive aspergillosis. serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). serious fungal infections caused by scedosporium spp and fusarium spp. other serious fungal infections, in patients intolerant of, or refractory to, other therapy. prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

BISOPROLOL SANDOZ bisoprolol fumarate 10 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

bisoprolol sandoz bisoprolol fumarate 10 mg film-coated tablet blister pack

sandoz pty ltd - bisoprolol fumarate, quantity: 10 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; iron oxide yellow; iron oxide red; macrogol 4000; titanium dioxide; hypromellose; lactose monohydrate - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

BISOPROLOL SANDOZ bisoprolol fumarate 5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

bisoprolol sandoz bisoprolol fumarate 5 mg film-coated tablet blister pack

sandoz pty ltd - bisoprolol fumarate, quantity: 5 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; croscarmellose sodium; iron oxide yellow; calcium hydrogen phosphate; colloidal anhydrous silica; pregelatinised maize starch; hypromellose; lactose monohydrate; macrogol 4000; titanium dioxide - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

BISOPROLOL SANDOZ bisoprolol fumarate 2.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

bisoprolol sandoz bisoprolol fumarate 2.5 mg film-coated tablet blister pack

sandoz pty ltd - bisoprolol fumarate, quantity: 2.5 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; pregelatinised maize starch; microcrystalline cellulose; calcium hydrogen phosphate; colloidal anhydrous silica; magnesium stearate; hypromellose; titanium dioxide; macrogol 4000; lactose monohydrate - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Capecitabine Sandoz 150 mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

capecitabine sandoz 150 mg film-coated tablets

rowex ltd - capecitabine - film-coated tablet - 150 milligram(s) - pyrimidine analogues; capecitabine

Capecitabine Sandoz 500 mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

capecitabine sandoz 500 mg film-coated tablets

rowex ltd - capecitabine - film-coated tablet - 500 milligram(s) - pyrimidine analogues; capecitabine

Capecitabine 150 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

capecitabine 150 mg film-coated tablets

fresenius kabi deutschland gmbh - capecitabine - film-coated tablet - 150 milligram(s) - pyrimidine analogues; capecitabine

Capecitabine 500 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

capecitabine 500 mg film-coated tablets

fresenius kabi deutschland gmbh - capecitabine - film-coated tablet - 500 milligram(s) - pyrimidine analogues; capecitabine

Capecitabine 150 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

capecitabine 150 mg film-coated tablets

fresenius kabi oncology plc - capecitabine - film-coated tablet - 150 milligram(s) - pyrimidine analogues; capecitabine